Seyed Ahmad Ashrafi, director of BioSyent Inc. (TSXV:RX), sold 11,800 Common Shares on the open market at an average of $16.48, a $195K sale between Sep 21, 2026 and Sep 22, 2026, disclosed Sep 25, 2026.
RX closed at $16.20 on Sep 25, 2026, up 16% over the prior three months. In the 52 weeks to that date it closed between $10.71 and $17.49. The average price was 5.8% below the Sep 22, 2026 close.
